One pill to rule them all? triple combo targets diabetes
NCT ID NCT06862739
First seen Apr 19, 2026 · Last updated May 02, 2026 · Updated 1 time
Summary
This study tests a single pill that combines three common diabetes medicines (empagliflozin, linagliptin, and metformin) to see if it helps adults with type 2 diabetes control their blood sugar better. The study involves 800 people aged 18-80 who have high blood sugar (HbA1c of 8% or more) and are already taking at least two diabetes drugs. The goal is to improve metabolic control, quality of life, and treatment satisfaction while reducing side effects like low blood sugar.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aap ka Clinic
RECRUITINGLahore, Punjab Province, Pakistan
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
-
Faisalabad clinics
RECRUITINGFaisalabad, Punjab Province, Pakistan
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.